Incidence, Clinical Presentation, and Predictors of Clinical Restenosis in Coronary Bioresorbable Scaffolds

Clinical End Points in Coronary Stent Trials

Donald E. Cutlip, Stephan Windecker, Roxana Mehran et al. · Circulation · 2007 · 5.4K citations

Regression modelling strategies for improved prognostic prediction

Frank E. Harrell, Kerry L. Lee, Robert M. Califf et al. · Statistics in Medicine · 1984 · 1.8K citations

Predictive Factors of Restenosis After Coronary Stent Placement

Adnan Kastrati, Albert Schömig, Shpend Elezi et al. · Journal of the American College of Cardiology · 1997 · 680 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Predictive Factors +6

Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial

Patrick W. Serruys, Bernard Chevalier, Yohei Sotomi et al. · The Lancet · 2016 · 534 citations · Full text

Percutaneous Coronary Intervention, Absorb Ii, Everolimus-eluting Metallic Stent +10

Vessel Size and Long-Term Outcome After Coronary Stent Placement

Shpend Elezi, Adnan Kastrati, Franz–Josef Neumann et al. · Circulation · 1998 · 478 citations